Literature DB >> 25024337

Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.

Antón Alvarez1, Manuel Aleixandre2, Carlos Linares3, Eliezer Masliah4, Herbert Moessler5.   

Abstract

Reduced brain-derived neurotrophic factor (BDNF) signaling is considered as a pathogenic event in early Alzheimer's disease (AD), but the influence of apathy and apolipoprotein E ε4 allele (APOE4) on serum BDNF values was not previously investigated in AD. We evaluated serum BDNF levels in AD, amnestic mild cognitive impairment (MCI), and control subjects. Baseline BDNF levels were similar in AD, MCI, and controls. AD patients having apathy showed lower BDNF values than patients without apathy (p < 0.05). After correction for the influence of apathy, APOE4 carriers showed lower BDNF levels (p < 0.01) and MMSE scores (p < 0.01) than non-APOE4 carriers in the subgroup of AD females, but not in males. Significant (p < 0.05) positive correlations between BDNF values and MMSE scores were only observed in subgroups of AD males and of AD patients without apathy. These results are showing the association of apathy and APOE4 with reduced serum BDNF levels in AD, and are suggesting that BDNF reductions might contribute to the worse cognitive performance exhibited by AD apathetic patients and female APOE4 carriers.

Entities:  

Keywords:  Alzheimer's disease; apathy; apolipoprotein E ε4 allele; brain-derived neurotrophic factor; elderly control subjects; mild cognitive impairment; serum

Mesh:

Substances:

Year:  2014        PMID: 25024337      PMCID: PMC4931817          DOI: 10.3233/JAD-140849

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  41 in total

Review 1.  The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits.

Authors:  Xuan Ye; Wenjiao Tai; Dan Zhang
Journal:  Neurobiol Aging       Date:  2011-12-31       Impact factor: 4.673

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

3.  Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

Authors:  Antón Alvarez; Ramón Cacabelos; Carolina Sanpedro; Manuel García-Fantini; Manuel Aleixandre
Journal:  Neurobiol Aging       Date:  2006-03-29       Impact factor: 4.673

4.  The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Authors:  D S Knopman; M J Knapp; S I Gracon; C S Davis
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

5.  Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.

Authors:  Jung Lee; Hiroaki Fukumoto; Jennifer Orne; Jochen Klucken; Susan Raju; Charles R Vanderburg; Michael C Irizarry; Bradley T Hyman; Martin Ingelsson
Journal:  Exp Neurol       Date:  2005-07       Impact factor: 5.330

6.  Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia.

Authors:  Jung Goo Lee; Bae Sub Shin; Young Sun You; Ji Eun Kim; Sung Wook Yoon; Dong Wook Jeon; Jun Hyung Baek; Sung Woo Park; Young Hoon Kim
Journal:  Psychiatry Investig       Date:  2009-11-11       Impact factor: 2.505

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Authors:  B Borroni; S Archetti; C Costanzi; M Grassi; M Ferrari; A Radeghieri; L Caimi; C Caltagirone; M Di Luca; A Padovani
Journal:  Neurobiol Aging       Date:  2008-01-07       Impact factor: 4.673

9.  Brain-derived neurotrophic factor levels in Alzheimer's disease.

Authors:  Sid E O'Bryant; Valerie Hobson; James R Hall; Stephen C Waring; Wenyan Chan; Paul Massman; Laura Lacritz; C Munro Cullum; Ramon Diaz-Arrastia
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease.

Authors:  Alan H Nagahara; David A Merrill; Giovanni Coppola; Shingo Tsukada; Brock E Schroeder; Gideon M Shaked; Ling Wang; Armin Blesch; Albert Kim; James M Conner; Edward Rockenstein; Moses V Chao; Edward H Koo; Daniel Geschwind; Eliezer Masliah; Andrea A Chiba; Mark H Tuszynski
Journal:  Nat Med       Date:  2009-02-08       Impact factor: 53.440

View more
  21 in total

1.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

2.  Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.

Authors:  Bo Yi Kim; Seon Heui Lee; Petra L Graham; Francesco Angelucci; Alejandro Lucia; Helios Pareja-Galeano; Thomas Leyhe; Yuda Turana; I Re Lee; Ji Hye Yoon; Jae Il Shin
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

3.  APOEε4 impacts up-regulation of brain-derived neurotrophic factor after a six-month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study.

Authors:  Joanne S Allard; Oyonumo Ntekim; Steven P Johnson; Julius S Ngwa; Vernon Bond; Dynell Pinder; Richard F Gillum; Thomas V Fungwe; John Kwagyan; Thomas O Obisesan
Journal:  Exp Gerontol       Date:  2016-11-15       Impact factor: 4.032

Review 4.  Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular disease.

Authors:  Alicia K Vose; Joseph F Welch; Jayakrishnan Nair; Erica A Dale; Emily J Fox; Gillian D Muir; Randy D Trumbower; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2021-10-09       Impact factor: 5.330

5.  Mediation Analyses of the Role of Apathy on Motoric Cognitive Outcomes.

Authors:  Mirnova E Ceïde; Daniel Eguchi; Emmeline I Ayers; David W Lounsbury; Joe Verghese
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

6.  Apathy is not associated with a panel of biomarkers in older adults with HIV disease.

Authors:  Steven Paul Woods; Jennifer L Thompson; Michelle A Babicz; Lokesh Shahani; Gabriela Delevati Colpo; Natalia P Rocha; Erin E Morgan; Antonio L Teixeira
Journal:  J Psychosom Res       Date:  2021-11-08       Impact factor: 4.620

7.  Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Shaoli Che; Irina Elarova; Yinghua Chen; Freddy Jeanneteau; Thorsten M Kranz; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Hippocampus       Date:  2017-09-27       Impact factor: 3.899

8.  Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).

Authors:  X-Y Qin; C Cao; N X Cawley; T-T Liu; J Yuan; Y P Loh; Y Cheng
Journal:  Mol Psychiatry       Date:  2016-04-26       Impact factor: 15.992

9.  Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.

Authors:  Jia Liu; Wei Yang; Hongyu Luo; Yixin Ma; Huan Zhao; Xiaojuan Dan
Journal:  Aging Clin Exp Res       Date:  2020-09-06       Impact factor: 3.636

10.  Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases.

Authors:  X Anton Alvarez; Irene Alvarez; Olalla Iglesias; Ignacio Crespo; Jesus Figueroa; Manuel Aleixandre; Carlos Linares; Elias Granizo; Manuel Garcia-Fantini; Jose Marey; Eliezer Masliah; Stefan Winter; Dafin Muresanu; Herbert Moessler
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-07       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.